E-LIB Suche - Ergebnisse für: Kartashov, Alex

1

Effectiveness, Safety, and Costs of Thromboprophylaxis with..:

Amin, Alpesh N. ; Kartashov, Alex ; Ngai, Wilson..
Journal of Health Economics and Outcomes Research. 11 (2024) 1 - p. , 2024

Link: https://doi.org/10.36469..

2

Effectiveness, Safety, and Costs of Thromboprophylaxis with..:

Amin, Alpesh ; Kartashov, Alex ; Ngai, Wilson..
Journal of Health Economics and Outcomes Research. , 2024

Link: https://doi.org/10.36469..

3

Effectiveness, safety, and costs of thromboprophylaxis with..:

Amin, Alpesh ; Kartashov, Alex ; Ngai, Wilson..
Frontiers in Cardiovascular Medicine. 10 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

4

Treatment patterns, healthcare resource use, and costs asso..:

Moon, Rena C. ; Marijam, Alen ; Mitrani-Gold, Fanny S....
PLOS ONE. 17 (2022) 11 - p. e0277713 , 2022

Link: https://doi.org/10.1371/..

5

Epidemiology of Invasive Escherichia coli Infection and Ant..:

Begier, Elizabeth ; Rosenthal, Ning A ; Gurtman, Alejandra...
Clinical Infectious Diseases. 73 (2021) 4 - p. 565-574 , 2021

Link: https://doi.org/10.1093/..

6

1434. Treatment Patterns, Healthcare Resource Use, and Asso..:

Moon, Rena ; Marijam, Alen ; Mitrani-Gold, Fanny S...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S798-S799 , 2021

Link: https://doi.org/10.1093/..

7

197. Healthcare Resource Utilization and Costs Associated w..:

Moon, Rena ; Marijam, Alen ; Mitrani-Gold, Fanny S...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S120-S120 , 2021

Link: https://doi.org/10.1093/..

8

Comparative Effectiveness and Costs of Enoxaparin Monothera..:

Rosenthal, Ning ; Xiao, Zhimin ; Kartashov, Alex..
American Journal of Cardiovascular Drugs. 21 (2020) 1 - p. 93-101 , 2020

Link: https://doi.org/10.1007/..

9

Contemporary trend of acute kidney injury incidence and inc..:

Prasad, Anand ; Rosenthal, Ning A. ; Kartashov, Alex..
Catheterization and Cardiovascular Interventions. 96 (2020) 6 - p. 1184-1197 , 2020

Link: https://doi.org/10.1002/..

10

Validation of test performance characteristics and minimal ..:

Nathan, Steven D. ; du Bois, Roland M. ; Albera, Carlo...
Respiratory Medicine. 109 (2015) 7 - p. 914-922 , 2015

Link: https://doi.org/10.1016/..

11

Risk of chemotherapy-induced febrile neutropenia with early..:

Weycker, Derek ; Li, Xiaoyan ; Barron, Rich...
Supportive Care in Cancer. 24 (2015) 6 - p. 2481-2490 , 2015

Link: https://doi.org/10.1007/..

12

Risk of febrile neutropenia in patients receiving emerging ..:

Weycker, Derek ; Li, Xiaoyan ; Edelsberg, John...
Supportive Care in Cancer. 22 (2014) 12 - p. 3275-3285 , 2014

Link: https://doi.org/10.1007/..

13

Risk and consequences of chemotherapy-induced neutropenic c..:

Weycker, Derek ; Barron, Rich ; Edelsberg, John...
BMC Health Services Research. 14 (2014) 1 - p. , 2014

Link: https://doi.org/10.1186/..

14

Retrospective Study of the Prevalence, Predictors, and Cons..:

Delea, Thomas E. ; Kartashov, Alex ; Sharma, Puza P.
Journal of Pharmacy Technology. 30 (2013) 1 - p. 21-30 , 2013

Link: https://doi.org/10.1177/..

15

Incidence, treatment, and consequences of chemotherapy-indu..:

Weycker, Derek ; Barron, Richard ; Kartashov, Alex..
Journal of Oncology Pharmacy Practice. 20 (2013) 3 - p. 190-198 , 2013

Link: https://doi.org/10.1177/..